Brett Davis talks to ecancer.tv about the how the increasing availability of electronic patient data is improving the standard of cancer treatment.

The wide spread adoption of electronic medical records and the falling cost of molecular profiling has increased the amount of data available to cancer clinicians and researchers.

This is helping to accelerate the translation of new discoveries into clinical practice and to allow the continuous monitoring of drug safety following approval. 

Filming supported by Amgen